Crystal structure of the urokinase receptor in a ligand-free form

Journal of Molecular Biology

Volumn 416, Issue 5, 2012, Pages 629-641

  Xu, Xiang ^a   Gårdsvoll, Henrik ^b,c   Yuan, Cai ^a,c,d   Lin, Lin ^a   Ploug, Michael ^b,c   Huang, Mingdong ^a,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FINSEN LABORATORY   (Denmark)

^c Centre for Proteases and Cancer   (China)

^d FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

Author keywords

crystal structure; ligand free; uPAR

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION; WILD TYPE; X RAY DIFFRACTION;

EID: 84863125697     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.12.058     Document Type: Article

References (58)

1. Ploug M. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor Curr. Pharm. Des. 9 2003 1499 1528 (Pubitemid 36758313)
2. Smith H.W., and Marshall C.J. Regulation of cell signalling by uPAR Nat. Rev., Mol. Cell Biol. 11 2010 23 36
3. Blasi F., and Carmeliet P. uPAR: a versatile signal orchestrator Nat. Rev., Mol. Cell Biol. 3 2002 932 943
4. Llinas P., Le Du M.H., Gårdsvoll H., Danø K., Ploug M., and Gilquin B. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide EMBO J. 24 2005 1655 1663 (Pubitemid 40704976)
5. Huai Q., Mazar A.P., Kuo A., Parry G.C., Shaw D.E., and Callahan J. Structure of human urokinase plasminogen activator in complex with its receptor Science 311 2006 656 659 (Pubitemid 43191309)
6. Liu S., Bugge T.H., and Leppla S.H. Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin J. Biol. Chem. 276 2001 17976 17984
7. Zhou H.M., Nichols A., Meda P., and Vassalli J.D. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis EMBO J. 19 2000 4817 4826
8. Bolon I., Zhou H.M., Charron Y., Wohlwend A., and Vassalli J.D. Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression Am. J. Pathol. 164 2004 2299 2304 (Pubitemid 38669375)
9. Connolly B.M., Choi E.Y., Gårdsvoll H., Bey A.L., Currie B.M., and Chavakis T. Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation Blood 116 2010 1593 1603
10. Danø K., Rømer J., Nielsen B.S., Bjørn S., Pyke C., Rygaard J., and Lund L.R. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types APMIS 107 1999 120 127 (Pubitemid 29133531)
11. Behrendt N. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling Biol. Chem. 385 2004 103 136 (Pubitemid 38461334)
12. Rabbani S.A., and Mazar A.P. The role of the plasminogen activation system in angiogenesis and metastasis Surg. Oncol. Clin. N. Am. 10 2001 393 415 x (Pubitemid 32472537)
13. Jo M., Thomas K.S., O'Donnell D.M., and Gonias S.L. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor J. Biol. Chem. 278 2003 1642 1646 (Pubitemid 36801395)
14. May A.E., Kanse S.M., Lund L.R., Gisler R.H., Imhof B.A., and Preissner K.T. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo J. Exp. Med. 188 1998 1029 1037 (Pubitemid 28443326)
15. Gyetko M.R., Sud S., Kendall T., Fuller J.A., Newstead M.W., and Standiford T.J. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection J. Immunol. 165 2000 1513 1519 (Pubitemid 30604586)
16. Rijneveld A.W., Levi M., Florquin S., Speelman P., Carmeliet P., and van Der Poll T. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia J. Immunol. 168 2002 3507 3511 (Pubitemid 34250418)
17. D'Mello V., Singh S., Wu Y., and Birge R.B. The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells J. Biol. Chem. 284 2009 17030 17038
18. Park Y.J., Liu G., Tsuruta Y., Lorne E., and Abraham E. Participation of the urokinase receptor in neutrophil efferocytosis Blood 114 2009 860 870
19. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., and Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin J. Biol. Chem. 269 1994 32380 32388
20. Deng G., Curriden S.A., Wang S., Rosenberg S., and Loskutoff D.J. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134 1996 1563 1571 (Pubitemid 26318027)
21. Høyer-Hansen G., Behrendt N., Ploug M., Danø K., and Preissner K.T. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction Febs Lett. 420 1997 79 85 (Pubitemid 28037204)
22. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V., and Chapman H.A. Regulation of integrin function by the urokinase receptor Science 273 1996 1551 1555 (Pubitemid 26301666)
23. Aguirre Ghiso J.A., Kovalski K., and Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling J. Cell Biol. 147 1999 89 104
24. Resnati M., Guttinger M., Valcamonica S., Sidenius N., Blasi F., and Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect EMBO J. 15 1996 1572 1582 (Pubitemid 26112379)
25. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Romano M., and Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R Proc. Natl Acad. Sci. USA 99 2002 1359 1364 (Pubitemid 34136498)
26. Czekay R.P., Kuemmel T.A., Orlando R.A., and Farquhar M.G. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity Mol. Biol. Cell 12 2001 1467 1479 (Pubitemid 33044425)
27. Colman R.W., Pixley R.A., Najamunnisa S., Yan W., Wang J., Mazar A., and McCrae K.R. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor J. Clin. Invest. 100 1997 1481 1487 (Pubitemid 27425773)
28. Chavakis T., Kanse S.M., Lupu F., Hammes H.P., Muller-Esterl W., and Pixley R.A. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions Blood 96 2000 514 522 (Pubitemid 30463370)
29. Mahdi F., Madar Z.S., Figueroa C.D., and Schmaier A.H. Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes Blood 99 2002 3585 3596 (Pubitemid 34534527)
30. LaRusch G.A., Mahdi F., Shariat-Madar Z., Adams G., Sitrin R.G., and Zhang W.M. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis Blood 115 2010 5111 5120
31. Madsen C.D., Ferraris G.M., Andolfo A., Cunningham O., and Sidenius N. uPAR-induced cell adhesion and migration: vitronectin provides the key J. Cell Biol. 177 2007 927 939 (Pubitemid 46873097)
32. Gårdsvoll H., and Ploug M. Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region J. Biol. Chem. 282 2007 13561 13572 (Pubitemid 47100512)
33. Gårdsvoll H., Danø K., and Ploug M. Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis J. Biol. Chem. 274 1999 37995 38003 (Pubitemid 30026869)
34. Huai Q., Zhou A., Lin L., Mazar A.P., Parry G.C., and Callahan J. Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes Nat. Struct. Mol. Biol. 15 2008 422 423 (Pubitemid 351483393)
35. Lin L., Gårdsvoll H., Huai Q., Huang M., and Ploug M. Structure-based engineering of species selectivity in the interaction between urokinase and its receptor: implication for preclinical cancer therapy J. Biol. Chem. 285 2010 10982 10992
36. Gårdsvoll H., Kjaergaard M., Jacobsen B., Kriegbaum M.C., Huang M., and Ploug M. Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor J. Biol. Chem. 286 2011 43515 43526
37. Ploug M., Rahbek-Nielsen H., Nielsen P.F., Roepstorff P., and Danø K. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells J. Biol. Chem. 273 1998 13933 13943 (Pubitemid 28268448)
38. Gårdsvoll H., Werner F., Søndergaard L., Danø K., and Ploug M. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites Protein Expression Purif. 34 2004 284 295 (Pubitemid 38390578)
39. Jacobsen B., Gårdsvoll H., Juhl Funch G., Ostergaard S., Barkholt V., and Ploug M. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry Protein Expression Purif. 52 2007 286 296 (Pubitemid 46150108)
40. Yuan C., Huai Q., Bian C.B., and Huang M. The expression, purification and crystallization of monomeric soluble human urokinase receptor Prog. Biochem. Biophys. 33 2006 277 281 (Pubitemid 43854679)
41. Gårdsvoll H., Jacobsen B., Kriegbaum M.C., Behrendt N., Engelholm L., Østergaard S., and Ploug M. Conformational regulation of urokinase receptor (uPAR) function. Impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction J. Biol. Chem. 286 2011 33544 33556
42. Barinka C., Parry G., Callahan J., Shaw D.E., Kuo A., and Bdeir K. Structural basis of interaction between urokinase-type plasminogen activator and its receptor J. Mol. Biol. 363 2006 482 495 (Pubitemid 44472493)
43. Gårdsvoll H., Gilquin B., Le Du M.H., Menez A., Jørgensen T.J.D., and Ploug M. Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking J. Biol. Chem. 281 2006 19260 19272 (Pubitemid 44035430)
44. Hansen A.P., Petros A.M., Meadows R.P., Nettesheim D.G., Mazar A.P., and Olejniczak E.T. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator Biochemistry 33 1994 4847 4864 (Pubitemid 24158434)
45. Ploug M., Ellis V., and Danø K. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor Biochemistry 33 1994 8991 8997 (Pubitemid 24258008)
46. Yuan C., and Huang M. Does the urokinase receptor exist in a latent form? Cell. Mol. Life Sci. 64 2007 1033 1037 (Pubitemid 46684549)
47. Ploug M., Behrendt N., Løber D., and Danø K. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator Semin. Thromb. Hemost. 17 1991 183 193
48. Degryse B., Resnati M., Czekay R.P., Loskutoff D.J., and Blasi F. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor J. Biol. Chem. 280 2005 24792 24803 (Pubitemid 40934570)
49. Sidenius N., Sier C.F., and Blasi F. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo FEBS Lett. 475 2000 52 56 (Pubitemid 30331077)
50. Ploug M. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor Curr. Pharm. Des. 9 2003 1499 1528 (Pubitemid 36758313)
51. Ploug M., Rahbek-Nielsen H., Ellis V., Roepstorff P., and Danø K. Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction Biochemistry 34 1995 12524 12534
52. Ploug M., Rønne E., Behrendt N., Jensen A.L., Blasi F., and Danø K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl- phosphatidylinositol J. Biol. Chem. 266 1991 1926 1933 (Pubitemid 21908387)
53. Ploug M., Kjalke M., Rønne E., Weidle U., Høyer-Hansen G., and Danø K. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins J. Biol. Chem. 268 1993 17539 17546 (Pubitemid 23236998)
54. Huang M.D., Mazar A.P., Parry G., Higazi A.A., Kuo A., and Cines D.B. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143) Acta Crystallogr., Sect. D: Biol. Crystallogr. 61 2005 697 700 (Pubitemid 43951510)
55. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 1997 Academic Press New York, NY 307 326 (Pubitemid 27085611)
56. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., and Grosse-Kunstleve R.W. Crystallography & NMR system: A new software suite for macromolecular structure determination Acta Crystallogr., Sect. D: Biol. Crystallogr. 54 1998 905 921
57. Jones T.A., Zou J.-Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the locations of errors in three models Acta Crystallogr. A 47 1991 110 119
58. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132 (Pubitemid 41742764)